Delivery Order SPE2DB24D2101-SPE2DB25FKLHZ
Award Date
6/11/25
Potential Completion Date
7/3/25
Potential Value
$7.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $10,099.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENHERTU 100 mg vials, a specialty pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of January 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This federal contract award, valued at $14,221.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENHERTU 100 MG VIALS, a pharmaceutical product, with a performance period ending on May 29, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial...
This federal contract award, valued at $31,998.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENHERTU 100 MG VIALS, a pharmaceutical product, with a performance period ending on March 12, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside designation used. AmerisourceBergen Drug Corp holds an...
This federal contract award is for the delivery of ENHERTU 100 MG VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $32,422.44, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is June 4, 2024. The contract is not designated as a set-aside. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENHERTU 100 MG VIALS, a medical product, with a firm fixed price of $17,777.00 and a completion date of June 9, 2025. The contract is not designated as a set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $44,442.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENHERTU 100 MG VIALS, a pharmaceutical product, with a completion date of April 29, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of ENHERTU 100 MG VIALS, a pharmaceutical product. It is a firm fixed-price delivery order contract with a ceiling value of $8,888.50 and a period of performance through June 26, 2025. The contract is not set-aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a larger...
This federal contract award is for the delivery of ENHERTU 100 MG vials to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense (DoD). The contract, valued at $16,117.70, was awarded to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor and supplier to the federal government. The contract is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of ENHERTU 100 MG VIALS, a medical product, with a ceiling value of $7,110.80 and a period of performance through July 2, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a $8,058.85 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of 4565174830 - ENHERTU 100 MG VIALS. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which DLA Troop Support Medical uses to procure a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not...